GoodRx Holdings Inc [GDRX] stock prices are down -3.23% to $8.08 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The GDRX shares have gain 23.55% over the last week, with a monthly amount glided 31.81%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 29, February 2024, GoodRx Reports Fourth Quarter and Full Year 2023 Results. In a post published today on Yahoo Finance, GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024.
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on March 01, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $10 from $7. Previously, Leerink Partners started tracking the stock with Outperform rating on February 26, 2024, and set its price target to $8. On January 02, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $4.50 on the stock. DA Davidson upgraded its rating to a Buy but stick to its price target of $9.50 on August 10, 2023. TD Cowen upgraded its rating to a Outperform and raised its price target to $12 on July 31, 2023. Citigroup started tracking with a Buy rating for this stock on December 01, 2022, and assigned it a price target of $7. In a note dated November 04, 2022, JP Morgan upgraded an Neutral rating on this stock and revised its target price from $10 to $8.
The stock price of GoodRx Holdings Inc [GDRX] has been fluctuating between $4.14 and $9.37 over the past year. Currently, Wall Street analysts expect the stock to reach $17.4 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $8.08 at the most recent close of the market. An investor can expect a potential return of 115.35% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
The GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 750.26M for trailing twelve months, representing a surge of 6.81%. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.79 points at the first support level, and at 7.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.33, and for the 2nd resistance point, it is at 8.58.
GoodRx Holdings Inc [GDRX] reported earnings per share of $0.08 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.07/share, meaning a difference of $0.01 and a surprise factor of 14.30%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.06 per share as compared to estimates of $0.06 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
It’s worth pointing out that GoodRx Holdings Inc [NASDAQ:GDRX]’s Current Ratio is 7.12. On the other hand, the Quick Ratio is 7.12, and the Cash Ratio is 5.49. Considering the valuation of this stock, the price to sales ratio is 4.24, the price to book ratio is 4.18.
Transactions by insiders
Recent insider trading involved Wagner Scott,, that happened on Nov 30 when 21652.0 shares were purchased., Wagner Scott completed a deal on Nov 29 to buy 26348.0 shares. Meanwhile, Wagner Scott bought 4157.0 shares on Nov 28.
